SequelSEC

EDAP TMS SA FOCL

Electromedical & Electrotherapeutic Apparatus · CIK 0001041934 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$70.53M
Fiscal year ended 2025-12-31
Operating income
-$24.69M
Fiscal year ended 2025-12-31
Free cash flow
Unavailable
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$61.85MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$1.65Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue0.9×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity3.2×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Electromedical & Electrotherapeutic Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Long-term debt / equity0.82x100th
Revenue YoY growth1.6%14th
Gross margin42.5%26th
Current ratio1.54x30th
R&D / revenue13.7%41th
Operating margin-35.0%46th
Net margin-41.5%52th

EDAP TMS SA (FOCL) reported revenue of $70.53M and net income of -$29.25M for the fiscal year ended 2025-12-31. This page shows 2 annual periods of income statement, balance sheet and cash flow figures normalized from EDAP TMS SA’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electromedical & Electrotherapeutic Apparatus.

Income

EDAP TMS SA income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Revenue$70.53M$69.40M
Cost of revenue$40.53M$40.65M
Gross profit$30.00M$28.74M
Operating income-$24.69M-$22.22M
Net income-$29.25M-$20.58M
Research & development$9.66M$8.36M
Weighted-average diluted sharesshares 37.44Mshares 37.29M
Pretax income-$28.81M-$20.27M
Income tax expense$438.00K$313.00K
Diluted EPS$-0.78$-0.55
Selling, general & administrative$45.04M$42.61M
General & administrative$17.72M$15.24M
Selling & marketing$27.32M$27.36M

Balance

EDAP TMS SA balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Cash & equivalents$20.45M$31.00M
Total assets$79.00M$89.41M
Current assets$57.16M$72.59M
Total liabilities$59.58M$46.92M
Current liabilities$37.14M$39.28M
Total equity incl. NCI$19.41M$42.48M
Temporary (mezzanine) equityUnavailableUnavailable
Inventory$7.77M$19.21M
Accounts receivable$14.95M$19.32M
Goodwill$757.00K$2.50M
Long-term debt$15.90M$2.25M
Accounts payableUnavailableUnavailable

Cash flow

EDAP TMS SA cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Operating cash flow-$16.41M-$14.70M
Capital expendituresUnavailableUnavailable
Investing cash flow-$5.72M-$4.46M
Financing cash flow$8.61M$5.02M
Net change in cash-$10.54M-$17.04M
Stock-based compensationUnavailableUnavailable
Common dividends paidUnavailableUnavailable
Common share repurchasesUnavailableUnavailable
Depreciation & amortization$3.41M$2.78M

Derived

EDAP TMS SA derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-31
Free cash flowUnavailableUnavailable
Gross margin42.5%41.4%
Operating margin-35.0%-32.0%
FCF marginUnavailableUnavailable
SBC / revenueUnavailableUnavailable
Current ratio1.54x1.85x
Revenue YoY growth1.6%Unavailable
Net margin-41.5%-29.7%
R&D / revenue13.7%12.1%
CapEx / revenueUnavailableUnavailable
Long-term debt / equity0.82xUnavailable
Effective tax rateUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open FOCL in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-14View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-03-25View SEC filing

Companies in the same industry

ADMT AXGN BLFS CBLL CNMD CV ECOR ELMD ESMC GTHP HCIL HYPR

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.